LIV Process, Inc.
June 23, 2026
Theater 4
Type: Company Presentation
Focus Area:
Infectious Disease and Vaccines
LIV Process is the first and only product in the world to provide microbial visualization of C. diff spores, the longest-living and one of the most dangerous pathogens in the world.
LIV Process is a transformative microbiological breakthrough merged with forensic light science providing illumination of viable C. diff spores on any surface. Up until this point, C. diff spores were invisible, thus posing a significant threat to the safety of patients, healthcare providers, and all of those present in the environment.
LIV Process’ mission is to Save Lives Now, speed adoption and accessibility of its breakthrough technology, and become a required protocol for infection prevention processes throughout the world.
Company HQ City:
Ardmore
Company HQ State:
Pennsylvania
Company HQ Country:
United States
Year Founded:
2017
Lead Product in Development:
Pathogen microbial visualization
CEO
Michael McIntyre
Development Phase of Lead Product
Multiple Products in Market
Number of Unlicensed Products Looking for Licensing
Three
When you expect your next catalyst update?
December 2026
What is your next catalyst (value inflection) update?
Third-party peer review evidence, early commercialization results, derivative application R&D expansion
Primary Speaker
)
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}